Radiotherapy with or without temozolomide in elderly patients aged ≥ 70 years with glioblastoma
Introduction : Although the recommended optimal treatment of glioblastoma multiforme (GBM) is adjuvant chemoradiotherapy, trials in GBM have excluded patients older than 70 years. In this study, we aimed to assess overall survival (OS) and prognostic factors in elderly patients (≥ 70 years) with new...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2016-08-01
|
| Series: | Contemporary Oncology |
| Subjects: | |
| Online Access: | https://www.termedia.pl/Radiotherapy-with-or-without-temozolomide-in-elderly-patients-aged-70-years-with-glioblastoma,3,28094,1,1.html |